Revolutionary transparent graphene microelectrodes enhance brain imaging and stimulation

The decoding of single-cell and average neural activities from surface potentials.

Semaglutide provides double benefit for women with heart failure

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure

June 24, 2024

Calorie restriction and therapy combo reshapes gut microbiome, boosts mental health in women

Study finds that combining caloric restriction with psychological interventions significantly alters the gut microbiome and improves stress-related mental health in women.

August 12, 2024

Brexanolone by Sage Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval

Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD).

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.